Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals

Federal Circuit

Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals

CourtCourt of Appeals for the Federal Circuit

DecidedJanuary 17, 2014

Docket13-1405

StatusUnpublished

This text of Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals (Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals, (Fed. Cir. 2014).

Pincite

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

CLASSEN IMMUNOTHERAPIES, INC., Plaintiff-Appellant,

v.

SOMAXON PHARMACEUTICALS, Defendant-Appellee. ______________________

2013-1405 ______________________

Appeal from the United States District Court for the Central District of California in No. 12-CV-6643, Judge Gary Feess. ______________________

JUDGMENT ______________________

JOSEPH J. ZITO, DNL ZITO, of Washington, DC, ar- gued for plaintiff-appellant. With him on the brief was BENJAMIN C. DEMING, of Los Angeles, California.

LISA J. PIROZZOLO, Wilmer Cutler Pickering Hale and Dorr, LLP, of Boston, Massachusetts, argued for defend- ant-appellee. With her on the brief were MARK C. FLEMING, and DAVID A. MANSPEIZER, of New York, New York. ______________________ THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (NEWMAN, DYK, and MOORE, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

January 17, 2014 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court

Free access — add to your briefcase to read the full text and ask questions with AI